NASDAQ:TGTX

TG Therapeutics Earnings Date, Estimates & History

$48.36

-1.65 (-3.30 %)

(As of 01/27/2021 11:03 AM ET)

Add

Compare

Today's Range

$48.00

Now: $48.36▼

$49.88

50-Day Range

$29.62

MA: $50.17▼

$54.90

52-Week Range

$6.34

Now: $48.36▼

$56.74

Volume35,001 shs

Average Volume1.65 million shs

Market Capitalization$6.36 billion

P/E RatioN/A

Dividend YieldN/A

Beta2.28

TG Therapeutics (NASDAQ:TGTX) Earnings Information

TG Therapeutics last announced its earnings results on November 9th, 2020. The biopharmaceutical company reported ($0.73) earnings per share for the quarter, missing the consensus estimate of ($0.41) by $0.32. The company earned $0.04 million during the quarter, compared to analysts' expectations of $0.04 million. TG Therapeutics has generated ($1.83) earnings per share over the last year. TG Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 2nd, 2021 based off prior year's report dates.

TG Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TG Therapeutics (NASDAQ:TGTX) Earnings Estimates

Current Year EPS Consensus Estimate: $-2.2 EPS
Next Year EPS Consensus Estimate: $-2 EPS

TG Therapeutics (NASDAQ TGTX) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Conference Call
3/2/2021 (Estimated)
11/9/2020	9/30/2020	($0.41)	($0.73)	($0.73)	$0.04 million	$0.04 million	N/A
8/10/2020	6/30/2020	($0.32)	($0.47)	($0.47)	$0.04 million	$0.04 million	Transcript
5/11/2020	3/31/2020	($0.36)	($0.48)	($0.48)	$0.04 million	$0.04 million	N/A
3/3/2020	12/31/2019	($0.45)	($0.44)	($0.32)	$0.04 million	$0.04 million	Transcript
11/12/2019	Q4	($0.36)	($0.69)	($0.65)	$0.04 million	$0.04 million	Transcript
8/9/2019	Q2 2019	($0.43)	($0.42)	($0.42)	$0.04 million	$0.04 million	N/A
5/10/2019	3/31/2019	($0.44)	($0.43)	($0.43)	$0.04 million	$0.04 million	N/A
11/9/2018	9/30/2018	($0.55)	($0.43)	($0.43)	$0.04 million	$0.04 million	N/A
8/7/2018	Q2 2018	($0.55)	($0.59)	($0.59)	$0.04 million	$0.04 million	N/A
5/8/2018	Q1 2018	($0.44)	($0.59)	($0.59)	$0.04 million	$0.04 million	N/A

3/8/2018	Q4 2017	($0.46)	($0.46)	($0.46)	$0.04 million	$0.04 million	N/A
11/8/2017	Q3 2017	($0.43)	($0.48)	($0.48)	$0.04 million	$0.04 million	N/A
8/9/2017	Q2 2017	($0.46)	($0.45)	($0.45)	$0.04 million	$0.04 million	Listen
5/5/2017	Q1 2017	($0.42)	($0.52)	($0.52)	$0.04 million	$0.04 million	N/A
3/10/2017	Q4 2016	($0.39)	($0.48)	($0.48)	$0.04 million	$0.04 million	N/A
11/7/2016	Q3 2016	($0.31)	($0.50)	($0.50)	$0.04 million	$0.04 million	Listen
8/8/2016	Q2 2016	($0.29)	($0.33)	($0.33)	$0.04 million	$0.04 million	N/A
5/10/2016	Q1 2016	($0.35)	($0.28)	($0.28)	$0.04 million	$0.04 million	Listen
3/7/2016	Q4 2015	($0.33)	($0.37)	($0.37)	$38.10 million	$38.10 million	N/A
11/9/2015	Q3 2015	($0.36)	($0.28)	($0.28)	$0.04 million	$0.04 million	N/A
8/10/2015	Q2 2015	($0.32)	($0.38)	($0.38)	$0.22 million	$0.04 million	Listen
5/4/2015	Q1 2015	($0.36)	($0.39)	($0.39)	$0.04 million	$0.04 million	N/A
3/11/2015	Q4 2014	($0.30)	($0.46)	($0.44)	$0.04 million	$0.04 million	N/A
11/10/2014	Q3 2014	($0.35)	($0.51)	($0.51)	$0.04 million	$0.04 million	N/A
7/21/2014	Q2 2014	($0.28)	($0.36)	($0.36)	$0.04 million	$0.04 million	N/A
5/12/2014	Q1 2014	($0.21)	($0.21)	($0.17)	$0.04 million	$0.04 million	Transcript
3/5/2014	Q4 2013	($0.19)	($0.18)	($0.17)	$40.00 million	$38.10 million	N/A
11/11/2013	Q3 2013	($0.25)	($0.16)	($0.16)	$0.03 million	$0.04 million	N/A
8/1/2013	Q2 2013	($0.18)	($0.29)	($0.29)		$0.04 million	N/A
5/13/2013	Q1 2013	($0.14)	($0.17)	($0.17)	$0.04 million	$0.04 million	N/A
3/21/2013	Q4 2012	($0.13)	($0.04)	($0.04)			N/A
11/8/2012	Q3 2012	($0.12)	($0.16)	($0.16)			N/A
11/14/2011	Q3 2011		($23.37)	($37.70)			N/A

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 1/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

TG Therapeutics Earnings Date, Estimates & History

Adding

Adding

Adding TG Therapeutics, Inc.

Earnings

TG Therapeutics (NASDAQ:TGTX) Earnings Information

TG Therapeutics Earnings Estimates and Actuals by Quarter

TG Therapeutics (NASDAQ:TGTX) Earnings Estimates

TG Therapeutics (NASDAQ TGTX) Earnings History by Quarter

30 Days of MarketBeat All Access for $1.00

Options Trading from Scratch

Market Data and Calendars

Investing Education and Resources